Excise classification of veterinary products turned on licensing, packaging and marketing; medicament and feed supplement treatment confirmed.

Excise classification of veterinary products depended on how they were licensed, registered, packaged, and marketed in trade. The first group of goods was treated as Ayurvedic Veterinary Medicaments because they appeared in the drug licence, were covered by registration for such medicaments, and were advertised and sold as medicines; classification under Heading 3003.30 up to 22-7-1996 and Heading 3003.39 thereafter was upheld. CALMIN and VIMIN were treated as animal feed supplements under Heading 23.02 because they were not listed in the drug licence, were outside the registration certificate, and were described only as cattle feed supplements. The brand-name and related duty and penalty issues were remitted for fresh decision, while extended limitation was upheld.

---

---

Issues: (i) Whether the products BLOTINOX, CATORRHOEA, CATGALL, DRESSOL, DEWORMIN, MAGGACITE, PROLLAPSE-IN, CATCOUGH, CATONE, DUGDH-DAN and UTEROTONE were classifiable as Ayurvedic Veterinary Medicaments under Heading 3003.30 up to 22-7-1996 and under Heading 3003.39 thereafter, or as animal feed under Heading 23.02; (ii) Whether the question of use of another person's brand name and the consequential duty and penalty liability required fresh consideration, and whether the extended period of limitation was invocable; (iii) Whether CALMIN and VIMIN were classifiable as animal feed supplements under Heading 23.02 or as medicaments under Heading 3003.30 and 3003.39.

Issue (i): Whether the products BLOTINOX, CATORRHOEA, CATGALL, DRESSOL, DEWORMIN, MAGGACITE, PROLLAPSE-IN, CATCOUGH, CATONE, DUGDH-DAN and UTEROTONE were classifiable as Ayurvedic Veterinary Medicaments under Heading 3003.30 up to 22-7-1996 and under Heading 3003.39 thereafter, or as animal feed under Heading 23.02.

Analysis: The products were supported by the Drug Licence and were entered therein as drugs permitted to be manufactured. The assessee had also obtained registration for manufacture of Ayurvedic Veterinary Medicaments, the packaging described the goods as veterinary medicines, and the goods were consistently advertised as medicines. These surrounding facts showed that the goods were marketed and understood as medicaments rather than as animal feed supplements.

Conclusion: The classification under Heading 3003.30 up to 22-7-1996 and under Heading 3003.39 thereafter was upheld, and the assessee failed on this issue.

Issue (ii): Whether the question of use of another person's brand name and the consequential duty and penalty liability required fresh consideration, and whether the extended period of limitation was invocable.

Analysis: The record showed that the brand-name dispute had not been properly appreciated in relation to the assessee's claim to continued user and the parallel challenge before the trade-mark authorities and the High Court. That issue therefore required reconsideration by the adjudicating authority. On limitation, the assessee had concealed the true nature of the goods and had represented them as animal feed supplements, which amounted to suppression of material facts justifying invocation of the extended period.

Conclusion: The brand-name issue and the consequential duty and penalty questions were remitted for fresh decision, while the extended period of limitation was held to be correctly invocable against the assessee.

Issue (iii): Whether CALMIN and VIMIN were classifiable as animal feed supplements under Heading 23.02 or as medicaments under Heading 3003.30 and 3003.39.

Analysis: These products were not listed as drugs in the Drug Licence, were not covered by the registration certificate for Ayurvedic Veterinary Medicaments, and were not marketed as medicines. Their packaging described them only as cattle feed supplements, supporting the view that they were not medicaments.

Conclusion: The classification of CALMIN and VIMIN under Heading 23.02 as animal feed supplements was upheld, and the Revenue failed on this issue.

Final Conclusion: The decision sustained the classification against the assessee for the first group of goods, upheld the classification in favour of the assessee for CALMIN and VIMIN, and remitted the brand-name related duty and penalty questions for fresh adjudication while affirming the invocation of the extended limitation period.

Ratio Decidendi: For excise classification, the manner in which the goods are licensed, described on packaging, registered, marketed, and understood in trade is decisive in determining whether they are medicaments or animal feed supplements.

---